Logo image of AAL

AMERICAN AIRLINES GROUP INC (AAL) Stock Fundamental Analysis

USA - NASDAQ:AAL - US02376R1023 - Common Stock

11.24 USD
-0.14 (-1.23%)
Last: 9/30/2025, 7:21:50 PM
11.2299 USD
-0.01 (-0.09%)
After Hours: 9/30/2025, 7:21:50 PM
Fundamental Rating

3

AAL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 21 industry peers in the Passenger Airlines industry. AAL may be in some trouble as it scores bad on both profitability and health. A decent growth rate in combination with a cheap valuation! Better keep an eye on AAL.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AAL was profitable.
AAL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AAL reported negative net income in multiple years.
AAL had a positive operating cash flow in 4 of the past 5 years.
AAL Yearly Net Income VS EBIT VS OCF VS FCFAAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

AAL's Return On Assets of 0.89% is in line compared to the rest of the industry. AAL outperforms 57.14% of its industry peers.
With a decent Return On Invested Capital value of 5.37%, AAL is doing good in the industry, outperforming 61.90% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AAL is significantly below the industry average of 14.49%.
Industry RankSector Rank
ROA 0.89%
ROE N/A
ROIC 5.37%
ROA(3y)0.96%
ROA(5y)-2.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.54%
ROIC(5y)N/A
AAL Yearly ROA, ROE, ROICAAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

AAL has a Profit Margin of 1.05%. This is comparable to the rest of the industry: AAL outperforms 57.14% of its industry peers.
In the last couple of years the Profit Margin of AAL has declined.
AAL has a Operating Margin of 5.12%. This is comparable to the rest of the industry: AAL outperforms 52.38% of its industry peers.
In the last couple of years the Operating Margin of AAL has declined.
The Gross Margin of AAL (64.95%) is better than 76.19% of its industry peers.
In the last couple of years the Gross Margin of AAL has remained more or less at the same level.
Industry RankSector Rank
OM 5.12%
PM (TTM) 1.05%
GM 64.95%
OM growth 3YN/A
OM growth 5Y-5.79%
PM growth 3YN/A
PM growth 5Y-15.78%
GM growth 3Y3.63%
GM growth 5Y0.67%
AAL Yearly Profit, Operating, Gross MarginsAAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AAL is destroying value.
AAL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AAL has more shares outstanding
Compared to 1 year ago, AAL has an improved debt to assets ratio.
AAL Yearly Shares OutstandingAAL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AAL Yearly Total Debt VS Total AssetsAAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

Based on the Altman-Z score of 0.71, we must say that AAL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AAL (0.71) is comparable to the rest of the industry.
AAL has a debt to FCF ratio of 19.12. This is a negative value and a sign of low solvency as AAL would need 19.12 years to pay back of all of its debts.
AAL's Debt to FCF ratio of 19.12 is fine compared to the rest of the industry. AAL outperforms 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.12
Altman-Z 0.71
ROIC/WACC0.81
WACC6.61%
AAL Yearly LT Debt VS Equity VS FCFAAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

AAL has a Current Ratio of 0.58. This is a bad value and indicates that AAL is not financially healthy enough and could expect problems in meeting its short term obligations.
AAL's Current ratio of 0.58 is in line compared to the rest of the industry. AAL outperforms 47.62% of its industry peers.
AAL has a Quick Ratio of 0.58. This is a bad value and indicates that AAL is not financially healthy enough and could expect problems in meeting its short term obligations.
AAL's Quick ratio of 0.48 is on the low side compared to the rest of the industry. AAL is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.48
AAL Yearly Current Assets VS Current LiabilitesAAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

4

3. Growth

3.1 Past

AAL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.04%.
The earnings per share for AAL have been decreasing by -17.21% on average. This is quite bad
The Revenue has been growing slightly by 1.50% in the past year.
Measured over the past years, AAL shows a small growth in Revenue. The Revenue has been growing by 3.44% on average per year.
EPS 1Y (TTM)7.04%
EPS 3YN/A
EPS 5Y-17.21%
EPS Q2Q%-12.84%
Revenue 1Y (TTM)1.5%
Revenue growth 3Y21.96%
Revenue growth 5Y3.44%
Sales Q2Q%0.4%

3.2 Future

The Earnings Per Share is expected to grow by 17.02% on average over the next years. This is quite good.
AAL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.28% yearly.
EPS Next Y-77.59%
EPS Next 2Y-5.21%
EPS Next 3Y9.25%
EPS Next 5Y17.02%
Revenue Next Year0.95%
Revenue Next 2Y3.46%
Revenue Next 3Y3.94%
Revenue Next 5Y3.28%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AAL Yearly Revenue VS EstimatesAAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
AAL Yearly EPS VS EstimatesAAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5 -10 -15 -20

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.39, the valuation of AAL can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of AAL indicates a rather cheap valuation: AAL is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.76, AAL is valued rather cheaply.
AAL is valuated cheaply with a Price/Forward Earnings ratio of 6.55.
AAL's Price/Forward Earnings ratio is rather cheap when compared to the industry. AAL is cheaper than 85.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.18. AAL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.39
Fwd PE 6.55
AAL Price Earnings VS Forward Price EarningsAAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AAL indicates a rather cheap valuation: AAL is cheaper than 95.24% of the companies listed in the same industry.
AAL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AAL is cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.75
EV/EBITDA 3.91
AAL Per share dataAAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.21%
EPS Next 3Y9.25%

0

5. Dividend

5.1 Amount

AAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN AIRLINES GROUP INC

NASDAQ:AAL (9/30/2025, 7:21:50 PM)

After market: 11.2299 -0.01 (-0.09%)

11.24

-0.14 (-1.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-16 2025-10-16/bmo
Inst Owners64.85%
Inst Owner Change-3.2%
Ins Owners1.4%
Ins Owner Change7.13%
Market Cap7.42B
Analysts71.85
Price Target13.59 (20.91%)
Short Float %11.1%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15%
Min EPS beat(2)9.67%
Max EPS beat(2)20.33%
EPS beat(4)4
Avg EPS beat(4)38.19%
Min EPS beat(4)9.67%
Max EPS beat(4)89.57%
EPS beat(8)7
Avg EPS beat(8)46.06%
EPS beat(12)10
Avg EPS beat(12)33.46%
EPS beat(16)13
Avg EPS beat(16)25.94%
Revenue beat(2)0
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-0.33%
Revenue beat(4)2
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)0.97%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.54%
Revenue beat(16)3
Avg Revenue beat(16)-0.54%
PT rev (1m)-0.88%
PT rev (3m)0.29%
EPS NQ rev (1m)2.31%
EPS NQ rev (3m)-301.35%
EPS NY rev (1m)-4.85%
EPS NY rev (3m)-52.01%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE 7.39
Fwd PE 6.55
P/S 0.14
P/FCF 4.75
P/OCF 1.81
P/B N/A
P/tB N/A
EV/EBITDA 3.91
EPS(TTM)1.52
EY13.52%
EPS(NY)1.72
Fwd EY15.27%
FCF(TTM)2.37
FCFY21.07%
OCF(TTM)6.2
OCFY55.2%
SpS82.22
BVpS-5.87
TBVpS-15.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.89%
ROE N/A
ROCE 7.33%
ROIC 5.37%
ROICexc 7.12%
ROICexgc 9.06%
OM 5.12%
PM (TTM) 1.05%
GM 64.95%
FCFM 2.88%
ROA(3y)0.96%
ROA(5y)-2.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.54%
ROIC(5y)N/A
ROICexc(3y)6.89%
ROICexc(5y)N/A
ROICexgc(3y)8.52%
ROICexgc(5y)N/A
ROCE(3y)7.55%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y3.25%
ROICexc growth 3YN/A
ROICexc growth 5Y2.18%
OM growth 3YN/A
OM growth 5Y-5.79%
PM growth 3YN/A
PM growth 5Y-15.78%
GM growth 3Y3.63%
GM growth 5Y0.67%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.12
Debt/EBITDA 5.03
Cap/Depr 112.74%
Cap/Sales 4.67%
Interest Coverage 1.55
Cash Conversion 81.52%
Profit Quality 275.66%
Current Ratio 0.58
Quick Ratio 0.48
Altman-Z 0.71
F-Score7
WACC6.61%
ROIC/WACC0.81
Cap/Depr(3y)120.38%
Cap/Depr(5y)92.28%
Cap/Sales(3y)5.27%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.04%
EPS 3YN/A
EPS 5Y-17.21%
EPS Q2Q%-12.84%
EPS Next Y-77.59%
EPS Next 2Y-5.21%
EPS Next 3Y9.25%
EPS Next 5Y17.02%
Revenue 1Y (TTM)1.5%
Revenue growth 3Y21.96%
Revenue growth 5Y3.44%
Sales Q2Q%0.4%
Revenue Next Year0.95%
Revenue Next 2Y3.46%
Revenue Next 3Y3.94%
Revenue Next 5Y3.28%
EBIT growth 1Y-2.7%
EBIT growth 3YN/A
EBIT growth 5Y-2.55%
EBIT Next Year26.07%
EBIT Next 3Y25.43%
EBIT Next 5Y25.86%
FCF growth 1Y-10.99%
FCF growth 3Y64.51%
FCF growth 5YN/A
OCF growth 1Y-5.78%
OCF growth 3Y78.19%
OCF growth 5Y0.87%